The facility comprises of 2 formulation development labs (OSD & Parenteral), 1 hormonal lab (under qualification), 4 analytical development labs (wet analysis lab, dissolution lab, instrumentation lab & GC lab), dedicated stability area, dedicated ware-house, central archival area and office space.
Formulation labs are designed to handle high potent compounds with an analytical sampling area.
Formulation labs have capabilities to offer development services for oral dosage forms (solids & liquids) as well as injectable dosage forms, including Lyophilization.
While the analytical labs are equipped with instruments that help in most of the analysis required for peroral and injectable dosage forms.
The stability area comprises of humidity chambers maintained at all ICH conditions, including photostability chamber.
Recognized by DSIR as in-house R&D unit and is also a DCGI – accredited testing laboratory.
Current capacity: up to 30 projects (both cytotoxic & non cytotoxic parenteral as well as OSD formulations).
